A Randomized, Placebo-Controlled Pilot Trial of Aprepitant Combined With Standard Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Undergoing Cyclophosphamide-Based Conditioning Regimens Prior to Hematopoietic Stem Cell Transplant (HSCT)
Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-018-0106-8
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2018
Authors
Publisher
Springer Science and Business Media LLC